VIZIENT, INC. for VIZIENT INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Not-for-profit Hospital Tax-exemption - Monitored IRS release of final 501R regulations finalizing new requirements for tax-exempt hospitals under the Affordable Care Act. Expressed opposition to proposals that would require firm percentage-based thresholds related to charity care and community benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD GOODMAN | — |
| CIDETTE PERRIN | — |
Medicare/Medicaid MMM
H.R. 2 - the Medicare and CHIP Reauthorization Act - Supported and advocated for passage of H.R. 2 to repeal the sustainable growth rate formula for Medicare reimbursement for physicians. Opposed possible inclusion of hospital payment cuts. Medicare Hospital Readmissions Reduction Program - Monitored implementation of the Medicare hospital readmissions reduction program. Supported passage of legislation (H.R. 1343 and S. 688, the Establishing Beneficiary Equity in the Hospital Readmission Program Act) that would require CMS to include socio-demographic conditions in calculating penalties under the program. Hospital Two-midnight Rule - Advocated for continuing enforcement delay of the CMS' two-midnight rule for short stay hospital admissions. Supported similar provision in H.R. 2. Rural Hospital Legislation - Monitored legislation (H.R. 169, the Critical Access Hospital Relief Act and H.R. 170, the Rural Health Care Provider Relief Act) that would relieve regulatory burden on rural hospitals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD GOODMAN | — |
| CIDETTE PERRIN | — |
Health Issues HCR
Hospital Group Purchasing - Conducted outreach and advocacy efforts to promote the value brought to the health care supply chain through hospital group purchasing organizations. Electronic Health Records - Monitored release of Meaningful Use Stage III rules for the Electronic Health Record Incentive Program. Advocated for the release of regulations that would provide added flexibility for providers to meet Stage II requirements in 2015. 340B Drug Discount Program - Tracked ongoing discussions about the role of the 340B drug discount program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD GOODMAN | — |
| CIDETTE PERRIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.